Literature DB >> 8914875

Importance of congestive heart failure and interaction of congestive heart failure and left ventricular systolic function on prognosis in patients with acute myocardial infarction.

L Køber1, C Torp-Pedersen, O D Pedersen, S Høiberg, A J Camm.   

Abstract

Left ventricular (LV) systolic function and congestive heart failure (CHF) are important predictors of long-term mortality after acute myocardial infarction. The importance of transient CHF and the interaction of CHF and LV function on prognosis has not been studied in detail previously. In the TRAndolapril Cardiac Evaluation Study, 6,676 consecutive patients with acute myocardial infarction 1 to 6 days earlier had LV systolic function quantified as wall motion index (echocardiography), which is closely correlated to LV ejection fraction. To study the interaction of CHF and wall motion index on long-term mortality, separate analyses were performed in patients with different levels of LV function. Risk ratio (95% confidence intervals [CI]) were determined from proportional hazard models subgrouped by wall motion index or CHF adjusted for age and gender. Heart failure was separated into transient or persistent. Wall motion index and CHF are correlated. Furthermore, there is an interaction between wall motion index and CHF. The prognostic importance of wall motion index depends on whether patients have CHF or not: the risk ratio associated with decreasing 1 wall motion index unit is 3.0 (2.6 to 3.4) in patients with CHF, and 2.2 (1.7 to 2.9) in patients without CHF when adjusted for age and gender. Similarly, the prognostic importance of CHF depends on the level of wall motion index: the risk ratio associated with CHF is 3.9 (1.8 to 8.3) when the wall motion index is <0.8 and 1.9 (1.5 to 2.3) when the wall motion index is >1.6. Transient CHF is an independent risk factor (risk ratio 1.5, confidence interval [CI] 1.3 to 1.8) although milder than persistent CHF (risk ratio 2.8, CI 2.5 to 3.2).

Entities:  

Mesh:

Year:  1996        PMID: 8914875     DOI: 10.1016/s0002-9149(96)90064-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.

Authors:  F Andersson; C Cline; T Rydén-Bergsten; L Erhardt
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

Review 2.  Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction.

Authors:  J G F Cleland; A Torabi; N K Khan
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

Review 3.  Therapies to prevent heart failure post-myocardial infarction.

Authors:  Kevin L Thomas; Eric J Velazquez
Journal:  Curr Heart Fail Rep       Date:  2005-12

Review 4.  Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction.

Authors:  Robin A P Weir; John J V McMurray
Journal:  Curr Heart Fail Rep       Date:  2006-12

Review 5.  Trandolapril. An update of its pharmacology and therapeutic use in cardiovascular disorders.

Authors:  D C Peters; S Noble; G L Plosker
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

6.  Pharmacological interventions for heart failure in people with chronic kidney disease.

Authors:  Meaghan Lunney; Marinella Ruospo; Patrizia Natale; Robert R Quinn; Paul E Ronksley; Ioannis Konstantinidis; Suetonia C Palmer; Marcello Tonelli; Giovanni Fm Strippoli; Pietro Ravani
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

7.  Clinical impact of estimated plasma volume status and its additive effect with the GRACE risk score on in-hospital and long-term mortality for acute myocardial infarction.

Authors:  Tsutomu Kawai; Daisaku Nakatani; Takahisa Yamada; Yasuhiko Sakata; Shungo Hikoso; Hiroya Mizuno; Shinichiro Suna; Tetsuhisa Kitamura; Katsuki Okada; Tomoharu Dohi; Takayuki Kojima; Bolrathanak Oeun; Akihiro Sunaga; Hirota Kida; Hiroshi Sato; Masatsugu Hori; Issei Komuro; Shunsuke Tamaki; Takashi Morita; Masatake Fukunami; Yasushi Sakata
Journal:  Int J Cardiol Heart Vasc       Date:  2021-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.